Nipun Padha’s research while affiliated with University of Delhi and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (2)


This figure illustrates the various staging and classification systems used in the diagnosis, treatment, and management of NBL; these systems help healthcare professionals assess the extent of the disease, predict outcomes, and guide treatment decisions
The diagram highlights the challenges posed by high-risk neuroblastoma, a type of cancer that often develops resistance to standard treatments. Epigenetic therapies offer a potential solution by targeting the mechanisms that control gene expression without altering the DNA sequence. These therapies primarily focus on three key areas: DNA methylation, histone modifications, and epigenetic readers. By manipulating these processes, researchers aim to disrupt the cancer cell’s ability to grow and spread, providing hope for patients with this aggressive form of the disease
This diagram highlights the identification and application of CTCs and exosome through liquid biopsy for increased detection, prognosis, and monitoring of neuroblastoma
This figure summarizes key factors in cancer progression and therapy resistance, including angiogenesis, drug resistance, metastasis, apoptosis, cell cycle arrest, and the role of hypoxia and ROS
This diagram illustrates the dynamic interaction between tumor cells and the immune system within the tumor microenvironment

+2

Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research
  • Literature Review
  • Publisher preview available

January 2025

·

70 Reads

Molecular Neurobiology

Rishabh Sharma

·

Jaya Yadav

·

·

[...]

·

This review explores the current understanding and recent advancements in neuroblastoma, one of the most common extracranial solid pediatric cancers, accounting for ~ 15% of childhood cancer-related mortality. The hallmarks of NBL, including angiogenesis, metastasis, apoptosis resistance, cell cycle dysregulation, drug resistance, and responses to hypoxia and ROS, underscore its complex biology. The tumor microenvironment’s significance in disease progression is acknowledged in this study, along with the pivotal role of cancer stem cells in sustaining tumor growth and heterogeneity. A number of molecular signatures are being studied in order to better understand the disease, with many of them serving as targets for the development of new therapeutics. This includes inhibitor therapies for NBL patients, which notably concentrate on ALK signaling, MDM2, PI3K/Akt/mTOR, Wnt, and RAS-MAPK pathways, along with regulators of epigenetic mechanisms. Additionally, this study offers an extensive understanding of the molecular therapies used, such as monoclonal antibodies and CAR-T therapy, focused on both preclinical and clinical studies. Radiation therapy’s evolving role and the promise of stem cell transplantation-mediated interventions underscore the dynamic landscape of NBL treatment. This study has also emphasized the recent progress in the field of diagnosis, encompassing the adoption of artificial intelligence and liquid biopsy as a non-intrusive approach for early detection and ongoing monitoring of NBL. Furthermore, the integration of innovative treatment approaches such as CRISPR-Cas9, and cancer stem cell therapy has also been emphasized in this review. Graphical Abstract

View access options

Exploring the Therapeutic Potential of Traditional Medicinal Foods in Cancer Treatment: Molecular Evidence and Bioactivities

September 2024

·

79 Reads

Current Topics in Medicinal Chemistry

Traditional medicinal foods derived from natural sources have gained increasing attention in recent years due to their perceived health benefits and potential therapeutic properties and are deeply rooted in cultural practices. This review aimed at understanding their potential health benefits, emphasizes the need to identify the key bioactive substances in traditional home medicine. We have discussed the bioactive properties, molecular targets, and anti-cancer effects of various compounds such as curcumin, genistein, berberine, resveratrol, and, quercetin present in traditional medicinal foods. Our study highlights the potential of traditional medicinal food in the prevention and management of various health conditions, including cardiovascular diseases, cancer and neurodegenerative disorders as evident from in vitro, in vivo and clinical trials. Additionally, our study explores the mechanistic action of various bioactive constituents of grapes, rosemary, barberry, turmeric and garlic that have been shown to interfere with cancer growth, proliferation, metastasis, angiogenesis, and induce apoptosis by targeting various pathways and the cell cycle. Additionally, a wide range of healing abilities of medicinal foods including their impact on cancer cells demonstrate their direct anti-tumor potential along with antioxidant and antiinflammatory properties. To summarize, the present review highlights that integrating the insights of contemporary science with the age-old wisdom of traditional medicine in a systematic way holds immense potential for developing alternate and effective approaches to cancer therapeutics and offering evidence-based dietary recommendations.